<?xml version="1.0" encoding="UTF-8"?>
<ref id="B139-vaccines-08-00468">
 <label>139.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Varricchio</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Capasso</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Della Volpe</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Malafronte</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Mansi</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Varricchio</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ciprandi</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Resveratrol plus carboxymethyl-Î²-glucan in children with recurrent respiratory infections: A preliminary and real-life experience</article-title>
  <source>Ital. J. Pediatr.</source>
  <year>2014</year>
  <volume>40</volume>
  <fpage>93</fpage>
  <pub-id pub-id-type="doi">10.1186/s13052-014-0093-3</pub-id>
  <pub-id pub-id-type="pmid">25416925</pub-id>
 </element-citation>
</ref>
